AP2615A - New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it - Google Patents
New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing itInfo
- Publication number
- AP2615A AP2615A AP2008004378A AP2008004378A AP2615A AP 2615 A AP2615 A AP 2615A AP 2008004378 A AP2008004378 A AP 2008004378A AP 2008004378 A AP2008004378 A AP 2008004378A AP 2615 A AP2615 A AP 2615A
- Authority
- AP
- ARIPO
- Prior art keywords
- agomelatine
- pharmaceutical compositions
- compositions containing
- reuptake inhibitor
- noradrenaline reuptake
- Prior art date
Links
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title 1
- 229960002629 agomelatine Drugs 0.000 title 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 title 1
- 229940126569 noradrenaline reuptake inhibitor Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0509206A FR2890564B1 (fr) | 2005-09-09 | 2005-09-09 | Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent |
| PCT/FR2006/002067 WO2007028904A1 (fr) | 2005-09-09 | 2006-09-08 | Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP2008004378A0 AP2008004378A0 (en) | 2008-04-30 |
| AP2615A true AP2615A (en) | 2013-03-14 |
Family
ID=36190808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2008004378A AP2615A (en) | 2005-09-09 | 2006-09-08 | New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it |
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US7622505B2 (de) |
| EP (1) | EP1769798B1 (de) |
| JP (2) | JP5395998B2 (de) |
| KR (1) | KR100863384B1 (de) |
| CN (1) | CN1927205A (de) |
| AP (1) | AP2615A (de) |
| AR (1) | AR056056A1 (de) |
| AT (1) | ATE404205T1 (de) |
| AU (1) | AU2006209368B2 (de) |
| BR (1) | BRPI0603759A (de) |
| CA (1) | CA2558782C (de) |
| CY (1) | CY1108319T1 (de) |
| DE (1) | DE602006002210D1 (de) |
| DK (1) | DK1769798T3 (de) |
| EA (1) | EA011650B1 (de) |
| ES (1) | ES2313590T3 (de) |
| FR (1) | FR2890564B1 (de) |
| GE (1) | GEP20094742B (de) |
| GT (1) | GT200600408A (de) |
| HR (1) | HRP20080535T3 (de) |
| JO (1) | JO2521B1 (de) |
| MA (1) | MA28505B1 (de) |
| ME (2) | ME02758B (de) |
| MX (1) | MXPA06010157A (de) |
| MY (1) | MY142260A (de) |
| NO (1) | NO338029B1 (de) |
| NZ (1) | NZ549725A (de) |
| PE (1) | PE20070429A1 (de) |
| PL (1) | PL1769798T3 (de) |
| PT (1) | PT1769798E (de) |
| RS (1) | RS50631B (de) |
| SA (1) | SA06270308B1 (de) |
| SG (1) | SG131030A1 (de) |
| SI (1) | SI1769798T1 (de) |
| TW (1) | TWI324513B (de) |
| UA (1) | UA83542C2 (de) |
| UY (1) | UY29778A1 (de) |
| WO (1) | WO2007028904A1 (de) |
| ZA (1) | ZA200607562B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2150525A1 (de) | 2007-05-01 | 2010-02-10 | Concert Pharmaceuticals Inc. | Naphthyl(ethyl)-acetamide |
| US20080280991A1 (en) * | 2007-05-08 | 2008-11-13 | Auspex Pharmaceuticals, Inc. | Substituted naphthalenes |
| CN102342924A (zh) * | 2010-08-05 | 2012-02-08 | 北京本草天源药物研究院 | 一种含有阿戈美拉汀的药物组合物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005002562A1 (en) * | 2003-07-04 | 2005-01-13 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitors and agomelatine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4843071A (en) * | 1986-12-05 | 1989-06-27 | Serotonin Industries Of Charleston | Method and composition for treating obesity, drug abuse, and narcolepsy |
| FR2658818B1 (fr) | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| ZA985765B (en) * | 1997-07-02 | 1999-08-04 | Merck & Co Inc | Polymorphic form of a tachykinin receptor antagonist. |
| JP2001520195A (ja) * | 1997-10-17 | 2001-10-30 | イーライ・リリー・アンド・カンパニー | 医薬の増強 |
| FR2834890B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'agomelatine |
| WO2003072138A1 (en) * | 2002-02-26 | 2003-09-04 | Ortho-Mcneil Pharmaceutical Inc. | Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents |
| JP2004292445A (ja) * | 2003-03-11 | 2004-10-21 | Katsunori Nonogaki | 糖尿病治療薬 |
| JP2007505095A (ja) * | 2003-09-12 | 2007-03-08 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | うつ病及び不安障害の治療のためのアルファ−２−デルタリガンド及びｓｓｒｉ及び／又はｓｎｒｉを含む組み合わせ |
-
2005
- 2005-09-09 FR FR0509206A patent/FR2890564B1/fr not_active Expired - Fee Related
-
2006
- 2006-08-22 MA MA29281A patent/MA28505B1/fr unknown
- 2006-08-31 UY UY29778A patent/UY29778A1/es not_active Application Discontinuation
- 2006-08-31 SG SG200605974-5A patent/SG131030A1/en unknown
- 2006-08-31 EA EA200601410A patent/EA011650B1/ru not_active IP Right Cessation
- 2006-09-04 CN CNA2006101289194A patent/CN1927205A/zh active Pending
- 2006-09-04 PE PE2006001067A patent/PE20070429A1/es not_active Application Discontinuation
- 2006-09-06 BR BRPI0603759-3A patent/BRPI0603759A/pt not_active Application Discontinuation
- 2006-09-06 SA SA06270308A patent/SA06270308B1/ar unknown
- 2006-09-07 MY MYPI20064102A patent/MY142260A/en unknown
- 2006-09-07 NZ NZ549725A patent/NZ549725A/en not_active IP Right Cessation
- 2006-09-07 JO JO2006305A patent/JO2521B1/en active
- 2006-09-07 US US11/516,877 patent/US7622505B2/en not_active Expired - Fee Related
- 2006-09-07 MX MXPA06010157A patent/MXPA06010157A/es active IP Right Grant
- 2006-09-07 GE GEAP20069612A patent/GEP20094742B/en unknown
- 2006-09-08 GT GT200600408A patent/GT200600408A/es unknown
- 2006-09-08 UA UAA200609700A patent/UA83542C2/uk unknown
- 2006-09-08 ME MEP-2008-631A patent/ME02758B/de unknown
- 2006-09-08 AP AP2008004378A patent/AP2615A/xx active
- 2006-09-08 ES ES06291421T patent/ES2313590T3/es active Active
- 2006-09-08 NO NO20064048A patent/NO338029B1/no not_active IP Right Cessation
- 2006-09-08 TW TW095133159A patent/TWI324513B/zh not_active IP Right Cessation
- 2006-09-08 RS RSP-2008/0504A patent/RS50631B/sr unknown
- 2006-09-08 DE DE602006002210T patent/DE602006002210D1/de active Active
- 2006-09-08 ME MEP-2008-504A patent/ME02767B/de unknown
- 2006-09-08 AR ARP060103907A patent/AR056056A1/es not_active Application Discontinuation
- 2006-09-08 EP EP06291421A patent/EP1769798B1/de active Active
- 2006-09-08 PT PT06291421T patent/PT1769798E/pt unknown
- 2006-09-08 AT AT06291421T patent/ATE404205T1/de active
- 2006-09-08 SI SI200630102T patent/SI1769798T1/sl unknown
- 2006-09-08 AU AU2006209368A patent/AU2006209368B2/en not_active Ceased
- 2006-09-08 ZA ZA200607562A patent/ZA200607562B/xx unknown
- 2006-09-08 WO PCT/FR2006/002067 patent/WO2007028904A1/fr not_active Ceased
- 2006-09-08 CA CA2558782A patent/CA2558782C/fr not_active Expired - Fee Related
- 2006-09-08 DK DK06291421T patent/DK1769798T3/da active
- 2006-09-08 PL PL06291421T patent/PL1769798T3/pl unknown
- 2006-09-11 JP JP2006245009A patent/JP5395998B2/ja not_active Expired - Fee Related
- 2006-09-11 KR KR1020060087622A patent/KR100863384B1/ko not_active Expired - Fee Related
-
2008
- 2008-09-04 CY CY20081100955T patent/CY1108319T1/el unknown
- 2008-11-05 HR HR20080535T patent/HRP20080535T3/xx unknown
-
2010
- 2010-12-21 JP JP2010284300A patent/JP2011088919A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005002562A1 (en) * | 2003-07-04 | 2005-01-13 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitors and agomelatine |
Non-Patent Citations (3)
| Title |
|---|
| CHILMAN-BLAIR K ET AL: "AGOMELATINE. ANTIDEPRESSANT TREATMENT OF BIPOLAR DISORDER MELATONIN AGONUST/5-HT20 ANTAGONIST" DRUGS OF THE FUTURE, BARCELONA, ES, vol. 28, no. 1, janvier 2003 (2003-01), pages 7-13, XP009036058 ISSN: 0377-8282 * |
| FLEISHAKER J C: "CLINICAL PHARMACOKINETICS OF REBOXETINE, A SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF PATIENTS WITH DEPRESSION" CLINICAL PHARMACOKINETICS, LEA & FEBIGER, PHILADELPHIA, PA, US, vol. 39, no. 6, 2000, pages 413-427, XP000991558 * |
| VERSIANI M: "THE SELECTIVE NORADRENALINE RE-UPTAKE INHIBITOR REBOXETINE HAS AN EARLY ONSET OF ANTIDEPRESSANT ACTION" INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, MARTIN DUNITZ, LONDON, GB, vol. 4, no. 4, 2000, pages 293-297, XP008039367 ISSN: 1365-1501 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT1993360T (lt) | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma | |
| ZA200802947B (en) | Stable pharmaceutical composition comprising a pyrimidine-sulfamide | |
| IL196136A (en) | Its aminoindane or salt derivative, the pharmaceutical composition containing them and their uses | |
| ZA200800408B (en) | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof | |
| ZA200803407B (en) | Frangrance product, dispenser, and dispenser assembly | |
| IL179371A0 (en) | 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor | |
| EP1941873A4 (de) | Metallo-beta-lactamase-hemmer | |
| IL166646A0 (en) | A new cosmetic composition | |
| EP1951244A4 (de) | Katalytische verbindungen | |
| PL1926477T3 (pl) | Kompozycja zawierająca NLPZ oraz paracetamol | |
| IL180557A0 (en) | Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor | |
| PL2168584T3 (pl) | Kompozycja farmaceutyczna zawierająca kombinację triazolobenzodiazepiny i selektywnego inhibitora wychwytu zwrotnego serotoniny | |
| EP1626950A4 (de) | Sertralinzusammensetzungen | |
| AP2615A (en) | New association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it | |
| AP2006003858A0 (en) | New association of a sinus node if inhibitor and acalcium inhibitor, and pharmaceutical composition s containing it | |
| GB0513248D0 (en) | Gas dispenser | |
| AU304349S (en) | Stamp | |
| EP1728515A4 (de) | Mittel zur hemmung einer infektion mit dem influenza-virus | |
| EP1906960A4 (de) | Neue kombination 1 | |
| ZA200607532B (en) | Association between agomelatine and a thymoregulatory agent, and pharmaceutical compositions containing it | |
| PT1931304E (pt) | Nova utilização de uma composição compreendendo cloridrato de cloroprocaína, uma nova composição compreendendo cloridrato de cloroprocaína e um método para o seu fabrico | |
| AU2003250467A1 (en) | Diaryl compounds as monoamine reuptake inhibitors | |
| HK1115371A (en) | Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof | |
| HK1120226A (en) | Tetralone-based monoamine reuptake inhibitors | |
| ZA200804195B (en) | Calcilytic compounds |